Hernia Repair Devices Global Market estimated to be worth $3.3 billion by 2022

Hernia is the protrusion of an internal organs or tissues through structure or muscle that contains it, the most common type occurs in the abdominal region. It is mainly caused by a combination of pressure and excessive muscular strain, weakness or injury of the abdominal wall. Generally, small or large intestine or intra-abdominal fat protrudes through the weakened abdominal wall. There are various types of hernias classified based on their anatomical locations into inguinal, incisional, umbilical and other types of hernias. The most common symptoms are pain, swelling, or a bulge and they can develop into an emergency if the hernia is strangulated. Surgery is most commonly recommended treatment for almost all types of hernia. Hernia repair devices are the medical devices that are used for the treatment of hernia and can be treated either by open surgery or laparoscopic surgery. Lately, robotic surgical techniques are also used to treat hernia, but they are expensive and are not adopted widely. According to IQ4I analysis, the Hernia repair devices global market is expected to reach $3,351.1 million by 2022.

Increasing demand for minimally invasive procedures, growing number of patients suffering from obesity, the rise in aging population and rising adoption of tension free repair procedures are driving the growth of hernia repair devices global market. However, Inconsistent reimbursements and high cost of hernia repair procedure, high implementation cost and stringent regulations posed on robotic surgery, operation failure in obese and Geriatric patients pose a threat of recurrence of hernia and also the risks and complications associated with hernia repair surgery and mesh are restraining the growth of hernia repair devices global market.

Technological advancements in hernia repair devices such as self-fixating (gripping) Mesh and the articulating fixation devices are designed to overcome the issues facing the laparoscopic procedure and also provide surgeons with greater access to weak spots within the abdominal wall and enable them to securely tack mesh into exact place. The fixation of mesh at complex sites is considered as the major concern in this market as the inappropriate fixation of mesh increases the chances of hernia recurrence and Hence, to overcome this problem, the manufacturers are focusing on high-flexibility and self-fixation of the hernia mesh where the mesh can be fixed at the hernia site without using any staples or glue and it is easy to advance the mesh towards the hernia site as it is more flexible. Furthermore, drug-eluting hernia meshes are a new advancement in this market which is in the development stage, these meshes elute drug such as sirolimus at the hernia site to reduce the infection rate through its antimicrobial activity. Minimally-Invasive procedures such as laparoscopic surgery are becoming popular globally as it offers better clinical outcomes than open surgical procedures. The recurrence rate of hernia repair decreases by 1-5% with the laparoscopic surgery from 5 to 30% with open hernia repair. In addition, with the adoption of robotic-assisted surgical techniques, hernia repairs is becoming popular as it reduces the rate of hernia recurrence, lowers pain and shortens hospital stays compared to the other procedures.

As the market is consolidated, protection of intellectual property rights plays a very important role as a long term strategy for survival of the company and to maintain a competitive advantage. According to IQ4I Analysis, J&J (Ethicon Inc.) filed the largest number of PCT applications followed by Medtronic and C.R.Bard at World Intellectual Property Organization (WIPO).

The Hernia repair devices global market is segmented based on their Hernia types, products, repair methods and geography. Among hernia types, inguinal hernia held the largest market share and is projected to keep the leading position. Among hernia repair Products, the hernia repair meshes held the largest market share, especially synthetic meshes. However, improved performance and increasing popularity of biological mesh will have a major impact on synthetic meshes market in the years to come. Among synthetic mesh types, the non-absorbable meshes held the largest market share. In hernia repair market by repair types, open-tension free repair held the largest market share. Increasing adoption and many of the advantages offered by laparoscopic tension free repair procedure will drive the adoption and are expected to grow at a faster rate.

Geographically, North American regions held the largest market share where U.S. dominates, the market is expected to show a strong growth due to the high advanced healthcare facilities, increased growing awareness about the technological advancements, availability of Medicare and third party insurance facilities, easy availability of skilled personnel are driving the market growth. Among European regions, Germany accounted for the largest share this growth is driven due to its high acceptance of advanced technologies and sophisticated universal treatment facilities. In Asia- Pacific region, China has held the largest market share due to its increase in healthcare spending and advancements in healthcare facilities, increasing adoption of tension-free hernia repair procedures, the easy access to advanced healthcare technology and affordability of hernia surgery.  In RoW regions, Brazil has the largest market share and is expected to grow at the strong rate due to increasing trends of medical tourism, large patient pool, Medicare facilities and increase in technological advancements.

Some of the major companies operating in the hernia repair devices market are C. R. Bard, Inc., (U.S.), Medtronic, Inc, (Ireland), Atrium medical (Getinge) (Sweden), Aspide medical (France), Cook medical (U.S.), J&J (Ethicon) (U.S.), and are considered to be the leaders in this space with their marketed products and strong pipelines. Followed by B. Braun Melsungen AG (Germany), Acelity L.P. Inc. (U.S.), W. L. Gore & Associates, Inc. (U.S.), Insightra Medical Inc. (U.S.). Some of the other players are A.M.I. GmbH (Austria), Angiologica BM Srl (Italy), Cousin Biotech (France), DSM Biomedical B.V., (Netherlands), Integra Lifesciences (U.S.), Assut Europe S.p.A. (Italy), etc.